Heparin effects on plasma lysolecithin formation and platelet aggregation.
D000217:Acyltransferases / Q000097:blood; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000293:Adolescent; D000328:Adult; D001799:Blood Sedimentation; D002784:Cholesterol / Q000097:blood; D003094:Collagen / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology; D004789:Enzyme Activation / Q000187:drug effects; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007275:Injections, Intravenous; D008244:Lysophosphatidylcholines / Q000096:biosynthesis* / Q000097:blood; D008297:Male; D008875:Middle Aged; D010713:Phosphatidylcholines / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011479:Protamines; D013431:Sulfates
D003911:Dextrans; D008244:Lysophosphatidylcholines; D010713:Phosphatidylcholines; D011479:Protamines; D013431:Sulfates; D000244:Adenosine Diphosphate; D006493:Heparin; D003094:Collagen; D002784:Cholesterol; D000217:Acyltransferases; D004837:Epinephrine